Company: BDRX
Filing Date: 2025-11-24
Form Type: 424B3
Source: 0001214659-25-017135
Chunk: 91

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-24
Form: 424B3
Chunk 91
---
16 of the Exchange Act. The SEC maintains an Internet site that contains reports, proxy,
information statements and other information regarding issuers at http://www.sec.gov. You can review our SEC filings and the registration
statement by accessing this website. Copies of certain information filed by us with the SEC are also available on our website at http://www.biodexapharma.com.
Our website is not a part of this prospectus and is not incorporated by reference in this prospectus.

<div align='center'>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</div>

The SEC allows us to “incorporate
by reference” the information we file with the SEC, which means that we can disclose important information to you by referring you
to another document filed separately with the SEC. The information incorporated by reference is an important part of this prospectus.
We incorporate by reference, as of their respective dates of filing, the documents listed below that we have filed with the SEC and any
documents that we file with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this prospectus
and prior to the termination of the offering of securities under this prospectus (except in each case the information contained in such
documents to the extent “furnished” and not “filed”):

Any statement contained in
any document incorporated by reference herein shall be deemed to be modified or superseded for purposes of this prospectus to the extent
that a statement contained in this prospectus modifies or supersedes such statement. Any statement so modified or superseded shall not
be deemed, except as so modified or superseded, to constitute a part of this prospectus.

We may incorporate by reference
into this prospectus, any Form 6-K meeting the requirements of Form F-1 which is submitted to the SEC after the date of this prospectus
and before the date of termination of this offering. Any such Form 6-K which we intend to so incorporate shall state in such form that
it is being incorporated by reference into this prospectus.

| 49 |

We will provide, without
charge to each person, including any beneficial owner, to whom this prospectus is delivered, upon written or oral request of such person,
a copy of any or all of the documents incorporated or deemed to be incorporated herein by reference other than exhibits, unless such exhibits
specifically are incorporated by reference into such documents or this document. Requests for such documents